Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918749 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Patients' self-reported outcome confirms good results with respect to tumor control and QOL after FSRT or SRS in patients with VS. SRS can be associated with higher side effect following a dose-dependency. In long-term follow-up, hearing deterioration is most likely attributed to normal aging, but not treatment-related.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stephanie E. Combs, Thomas Welzel, Kerstin Kessel, Daniel Habermehl, Stefan Rieken, Oliver Schramm, Jürgen Debus,